Standard BioTools Inc expected to post a loss of 13 cents a share - Earnings Preview

Standard BioTools

27/02/2024 01:10

* Standard BioTools Inc  LAB.OQ   LAB.O  is expected to show
a
fall in quarterly revenue when it reports  results on February
28 for the period ending December 31 2023
    * The South San Francisco California-based  company is
expected to
report a 9.9% decrease in revenue to $24.9 million from $27.64
million a year ago, according to the estimate from one analyst,
based on LSEG data.The company's guidance on January 8 2024, for
the period ended December 31, was for revenue of $28.000
million.
    * ​LSEG's mean analyst estimate for Standard BioTools Inc is
for a
loss of 13 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Standard
BioTools
Inc is $4.00​, above​ its last closing price of $2.38. ​​​

This summary was machine generated February 27 at 01:10 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)